Breaking News

Japan Unexpectedly Targets Bigger Expansion of Monetary Base; Yen Drops; Nikkei 225 Surges
Tweet TWEET

Investor Alert: Holzer Holzer & Fistel, LLC Advises Investors of Upcoming Deadlines in Shareholder Litigation Involving Delcath

  Investor Alert: Holzer Holzer & Fistel, LLC Advises Investors of Upcoming
  Deadlines in Shareholder Litigation Involving Delcath Systems, Inc., Amyris,
  Inc., Nam Tai Electronics, Inc. and Accretive Health, Inc.

Business Wire

ATLANTA -- June 18, 2013

Holzer Holzer & Fistel LLC reminds investors of upcoming deadlines for
applications to serve as lead plaintiff in securities class action lawsuits
against Delcath Systems, Inc. (DCTH), Amyris, Inc. (AMRS), Nam Tai
Electronics, Inc. (NTE) and Accretive Health, Inc. (AH).

Investors that suffered significant losses investing in any of these companies
during the specified times who are interested in potentially serving as lead
plaintiff in the respective class actions are encouraged to contact Michael I.
Fistel, Jr., Esq. (mfistel@holzerlaw.com) or Marshall P. Dees, Esq.
(mdees@holzerlaw.com) by email or via toll-free telephone at (888) 508-6832 to
discuss their legal rights.

A lead plaintiff is a representative party appointed by the court to act on
behalf of other class members in directing the litigation. Any member of the
purported class may move the court to serve as lead plaintiff through counsel
of their choice, or may choose to do nothing and remain an absent class
member.

Delcath Systems Inc.

A class action lawsuit has been filed on behalf of investors who purchased
Delcath (NASDAQ: DCTH) common stock between April 21, 2010 and May 2, 2013,
inclusive, alleging the company violated the federal securities laws by, among
other things, misrepresenting the status of its New Drug Application for the
commercial sale of its Melblez Kit.

The deadline to seek appointment as lead plaintiff in this lawsuit, which is
pending in the United States District Court for the Eastern District of
Pennsylvania, is July 8, 2013. More information about the lawsuit and the firm
are available at www.holzerlaw.com.

Amyris, Inc.

A class action lawsuit has been filed on behalf of investors who purchased
Amyris, Inc. (NASDAQ: AMRS) common stock between April 29, 2011 and February
8, 2012. The lawsuit alleges the company violated the federal securities laws
by issuing false and misleading statements regarding Amyris’s ability to
commercially produce Biofene.

The deadline to seek appointment as lead plaintiff in this lawsuit, which is
pending in the United States District Court for the Northern District of
California, is July 15, 2013. More information about the lawsuit and the firm
are available at www.holzerlaw.com.

Nam Tai Electronics

A class action lawsuit has been filed on behalf of investors who purchased
securities of Nam Tai Electronics (NYSE: NTE) between August 6, 2012 and April
26, 2013. According to the complaint, Nam Tai made false and misleading
statements to investors during that time regarding demand for its products and
its ability to withstand competition and volatility in the market for liquid
crystal display modules.

The deadline to seek appointment as lead plaintiff in this matter, which is
pending in the United States District Court for the Southern District of New
York, is July 16, 2013. More information about the lawsuit and the firm are
available at www.holzerlaw.com.

Accretive Health, Inc.

A class action lawsuit has been filed on behalf of investors who purchased
Accretive Health, Inc. (NYSE: AH) common stock between May 20, 2010 and
February 26, 2013, inclusive, including purchases made pursuant to the
company’s initial public offering. The complaint alleges that Accretive Health
issued false and misleading financial statements that did not conform to
Generally Accepted Accounting Principles. On February 26, 2013, Accretive
announced that it would postpone the release of its financial results for the
fourth quarter and full year 2012 because it was evaluating the timing of
revenue recognition for its revenue cycle management agreements. The company’s
stock price declined dramatically on the news.

The deadline to seek appointment as lead plaintiff in this lawsuit, which is
pending in the United States District Court for the Northern District of
Illinois, is July 19, 2013. More information about the lawsuit and the firm
are available at www.holzerlaw.com.

About The Firm

Holzer Holzer & Fistel, LLC dedicates its practice to vigorous representation
of shareholders and investors in litigation nationwide, including shareholder
class action and derivative litigation. More information about the firm is
available through its website, www.holzerlaw.com and upon request from the
firm. Holzer Holzer & Fistel, LLC has paid for the dissemination of this
promotional communication, and Michael I. Fistel, Jr. is the attorney
responsible for its content.

Contact:

Holzer Holzer & Fistel, LLC
Michael I. Fistel, Jr., Esq.
Marshall P. Dees, Esq.
888-508-6832 (toll-free)
mfistel@holzerlaw.com
mdees@holzerlaw.com
 
Press spacebar to pause and continue. Press esc to stop.